Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Setmelanotide

Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity

Rhythm · Phase 2 · Completed · Enrollment 213

NCT03013543

EudraCT 2017-000387-14

No selected arm has a reported week for this endpoint.

    A solid line connects the weeks the source reports.